<DOC>
	<DOC>NCT01269658</DOC>
	<brief_summary>The purpose of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% versus vehicle over a four-week treatment period in treating the signs and symptoms of subjects with blepharitis and to evaluate the clinical course of the condition under study.</brief_summary>
	<brief_title>A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)</brief_title>
	<detailed_description />
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Have a current diagnosis of blepharitis Have a best corrected visual acuity (BCVA), using corrective lenses if necessary, in both eyes of at least +0.7 If female, are nonpregnant or nonlactating Have a concurrent acute hordeolum (stye) or chalazion Have inflammation of the ocular surface Have used artificial tears within 48 hours prior to Visit 1 or anticipate using during the study Have had ocular surgery in the past 90 days or will require it during the study Unable to withhold the use of contact lenses during the study Have a known hypersensitivity to azithromycin, erythromycin, any other macrolide antibiotic, or any of the other ingredients in the study medication Have been diagnosed with ongoing glaucoma Unable to withhold the use of ocular cosmetic products within 48 hours prior to Visit 1 and throughout the study Have a serious medical condition which could confound study assessments</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>